HALEY QUINTANA: Open Payments
NPI 1083231807 · MAGNOLIA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 33 payments from 11 companies in 2025. Trend: 2023 $91 · 2024 $717 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| ABBVIE INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Exact Sciences Corporation | 2 | $31 |
| Dexcom, Inc. | 2 | $30 |
| PFIZER INC. | 2 | $30 |
Products named: MOUNJARO, FARXIGA, CAPLYTA, BREZTRI, JARDIANCE, Rybelsus, TRINTELLIX, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
